世界および日本の化学療法誘発性血小板減少症治療薬の市場規模、現状および予測2021-2027年

Global and Japan Chemotherapy Induced Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027

化学療法は、さまざまな形態のがん患者に行われるがん治療法です。化学療法には、アルキル化剤、代謝拮抗剤、標的療法、免疫療法など、さまざまな薬剤が使用される。これらの化学療法剤は、がん細胞および正常細... もっと見る

出版社	出版年月	電子版価格	言語
QYResearch QYリサーチ	2021年11月19日	US$3,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

化学療法は、さまざまな形態のがん患者に行われるがん治療法です。化学療法には、アルキル化剤、代謝拮抗剤、標的療法、免疫療法など、さまざまな薬剤が使用される。これらの化学療法剤は、がん細胞および正常細胞に作用し、体内のあらゆる種類の細胞を減少させます。がん治療によって正常な血小板が死滅し、正常に機能する血小板の数が減少した状態を「化学療法誘発性血小板減少症」と呼びます。

市場分析と洞察。化学療法誘発性血小板減少症治療薬の世界市場
化学療法誘発性血小板減少症治療薬の世界市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX％のCAGRで推移し、2027年にはXX百万米ドルに達すると予測されます。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の化学療法誘発性血小板減少症治療薬市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つことを目的としています。本レポートの購入者は、検証された信頼性の高い市場予測にアクセスすることができ、その中には収益面での世界のChemotherapy Induced Thrombocytopenia Drugs（化学療法誘発性血小板減少症治療薬）市場の全体的なサイズも含まれています。
本レポートは、化学療法誘発性血小板減少症治療薬の世界市場において、競合他社よりも優位に立ち、永続的な成功を収めるための効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の化学療法誘発性血小板減少症治療薬市場を詳細に調査するために、ユニークで業界最高の調査・分析アプローチを採用しました。

世界の化学療法誘発性血小板減少症治療薬の範囲と市場規模
化学療法誘発性血小板減少症治療薬市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界のChemotherapy Induced Thrombocytopenia Drugs（化学療法誘発性血小板減少症治療薬）市場のプレーヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
経口剤
注射剤タイプの薬剤

用途別セグメント
病院薬局
小売薬局
オンライン薬局

地域別
北アメリカ
U.S.
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
アムジェン
ノバルティス
Teva
マイラン
ファイザー
ジョンソン・エンド・ジョンソン
ミッションファーマカル
マイロ・セラピューティクス
ドバ・ファーマシューティカルズ

ページTOPに戻る

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotherapy Induced Thrombocytopenia Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Drugs
1.2.3 Injectable Drugs
1.3 Market by Application
1.3.1 Global Chemotherapy Induced Thrombocytopenia Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Chemotherapy Induced Thrombocytopenia Drugs Market Perspective (2016-2027)
2.2 Chemotherapy Induced Thrombocytopenia Drugs Growth Trends by Regions
2.2.1 Chemotherapy Induced Thrombocytopenia Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Chemotherapy Induced Thrombocytopenia Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Chemotherapy Induced Thrombocytopenia Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Chemotherapy Induced Thrombocytopenia Drugs Industry Dynamic
2.3.1 Chemotherapy Induced Thrombocytopenia Drugs Market Trends
2.3.2 Chemotherapy Induced Thrombocytopenia Drugs Market Drivers
2.3.3 Chemotherapy Induced Thrombocytopenia Drugs Market Challenges
2.3.4 Chemotherapy Induced Thrombocytopenia Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Chemotherapy Induced Thrombocytopenia Drugs Players by Revenue
3.1.1 Global Top Chemotherapy Induced Thrombocytopenia Drugs Players by Revenue (2016-2021)
3.1.2 Global Chemotherapy Induced Thrombocytopenia Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Chemotherapy Induced Thrombocytopenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Chemotherapy Induced Thrombocytopenia Drugs Revenue
3.4 Global Chemotherapy Induced Thrombocytopenia Drugs Market Concentration Ratio
3.4.1 Global Chemotherapy Induced Thrombocytopenia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotherapy Induced Thrombocytopenia Drugs Revenue in 2020
3.5 Chemotherapy Induced Thrombocytopenia Drugs Key Players Head office and Area Served
3.6 Key Players Chemotherapy Induced Thrombocytopenia Drugs Product Solution and Service
3.7 Date of Enter into Chemotherapy Induced Thrombocytopenia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Chemotherapy Induced Thrombocytopenia Drugs Breakdown Data by Type
4.1 Global Chemotherapy Induced Thrombocytopenia Drugs Historic Market Size by Type (2016-2021)
4.2 Global Chemotherapy Induced Thrombocytopenia Drugs Forecasted Market Size by Type (2022-2027)

5 Chemotherapy Induced Thrombocytopenia Drugs Breakdown Data by Application
5.1 Global Chemotherapy Induced Thrombocytopenia Drugs Historic Market Size by Application (2016-2021)
5.2 Global Chemotherapy Induced Thrombocytopenia Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size (2016-2027)
6.2 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type
6.2.1 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2021)
6.2.2 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2022-2027)
6.2.3 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2027)
6.3 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application
6.3.1 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2021)
6.3.2 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2022-2027)
6.3.3 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2027)
6.4 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country
6.4.1 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2016-2021)
6.4.2 North America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size (2016-2027)
7.2 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type
7.2.1 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2021)
7.2.2 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2022-2027)
7.2.3 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2027)
7.3 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application
7.3.1 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2021)
7.3.2 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2022-2027)
7.3.3 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2027)
7.4 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country
7.4.1 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2016-2021)
7.4.2 Europe Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size (2016-2027)
8.2 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type
8.2.1 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application
8.3.1 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Region
8.4.1 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Chemotherapy Induced Thrombocytopenia Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size (2016-2027)
9.2 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type
9.2.1 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2027)
9.3 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application
9.3.1 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2027)
9.4 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country
9.4.1 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size (2016-2027)
10.2 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type
10.2.1 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application
10.3.1 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country
10.4.1 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Chemotherapy Induced Thrombocytopenia Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.1.4 Amgen Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.2.4 Novartis Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.3.4 Teva Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.4.4 Mylan Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.5.4 Pfizer Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Mission Pharmacal
11.7.1 Mission Pharmacal Company Details
11.7.2 Mission Pharmacal Business Overview
11.7.3 Mission Pharmacal Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.7.4 Mission Pharmacal Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.7.5 Mission Pharmacal Recent Development
11.8 Myelo Therapeutics
11.8.1 Myelo Therapeutics Company Details
11.8.2 Myelo Therapeutics Business Overview
11.8.3 Myelo Therapeutics Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.8.4 Myelo Therapeutics Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.8.5 Myelo Therapeutics Recent Development
11.9 Dova Pharmaceuticals
11.9.1 Dova Pharmaceuticals Company Details
11.9.2 Dova Pharmaceuticals Business Overview
11.9.3 Dova Pharmaceuticals Chemotherapy Induced Thrombocytopenia Drugs Introduction
11.9.4 Dova Pharmaceuticals Revenue in Chemotherapy Induced Thrombocytopenia Drugs Business (2016-2021)
11.9.5 Dova Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

ページTOPに戻る

Table of Contents

Summary

Chemotherapy is the cancer treatment given to patients with different forms of the cancer. Various drugs such as alkylating agents, antimetabolites, targeted therapy, immunotherapy drugs, etc. are used for the cancer treatment. These chemotherapy agents acts against the cancerous as well as normal cells, resulting in decreased number of the cells of all types in the body. Cancer therapy which results in the killing of normal thrombocytes resulting in decreased number of normally functioning thrombocytes, the condition is called as the chemotherapy induced thrombocytopenia.

Market Analysis and Insights: Global Chemotherapy Induced Thrombocytopenia Drugs Market
The global Chemotherapy Induced Thrombocytopenia Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Chemotherapy Induced Thrombocytopenia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Chemotherapy Induced Thrombocytopenia Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Chemotherapy Induced Thrombocytopenia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Chemotherapy Induced Thrombocytopenia Drugs market.

Global Chemotherapy Induced Thrombocytopenia Drugs Scope and Market Size
Chemotherapy Induced Thrombocytopenia Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chemotherapy Induced Thrombocytopenia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Drugs
Injectable Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Amgen
Novartis
Teva
Mylan
Pfizer
Johnson & Johnson
Mission Pharmacal
Myelo Therapeutics
Dova Pharmaceuticals

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（在宅・地域医療）の最新刊レポート

QYResearch社の在宅・地域医療分野での最新刊レポート

本レポートと同じKEY WORD（chemotherapy）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

世界および日本の化学療法誘発性血小板減少症治療薬の市場規模、現状および予測2021-2027年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（在宅・地域医療）の最新刊レポート

QYResearch社の在宅・地域医療分野での最新刊レポート

本レポートと同じKEY WORD（chemotherapy）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?